Companies
- Companies
- Browse
Companies
Development of the Magnetic Plungerless Injection System More
Healthcare Strategy Consultants: Management Consulting More
MetaPhore is an emerging drug discovery and development company that is applying its proprietary superoxide dismutase (SOD) enzyme mimetic technology to address significant unmet medical needs. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Feb 2011 - 68 pages - $1,040
Feb 2007 - 10 pages - $1,295
Mar 2010 - 414 pages - $690
Jan 2011 - 38 pages - $515
Apr 2010 - 42 pages - $515
Mar 2010 - 30 pages - $515
May 2009 - 32 pages - $515
Jul 2005 - 52 pages - $515
Feb 2009 - 242 pages - $690
Nov 2009 - 77 pages - $1,000
Your selection
Browse By
- Industry sector
- Therapeutic device
- Therapeutic medical equipment
- Vision Care
- Therapeutic target
- Acne
- Actinic keratosis
- Alopecia
- Bacterial infection
- Burns
- Chronic idiopathic urticaria
- Cosmetic procedures
- Dermal ulcers
- Dermatitis, allergic
- Dermatitis, atopic
- Dermatological (other)
- Dermatosis
- Eczema
- Fungal infection
- Hirsutism
- Human B19 parvovirus
- Hyperkeratosis
- Ichthyosis
- Impetigo
- Insect bite
- Keloids
- Lupus
- Male pattern baldness
- Paget's disease
- Photodamage
- Pruritis
- Psoriasis
- Scleroderma
- Shingles
- Skin infection (other)
- Ulcer, diabetic
- Urticaria
- Wound healing
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us